FDA committee to discuss adverse effects of testosterone products

July 17, 2014 6:39 PM

8 0

FDA committee to discuss adverse effects of testosterone products

The 3D printing revolution

(Reuters) - The U.S. Food and Drug Administration has called an advisory committee meeting on Sept. 17, to discuss the adverse cardiovascular outcomes with the usage of testosterone replacement therapy.

Read more

To category page

Loading...